Amphastar Pharmaceuticals AMPH
NASDAQ AMPH
$25.94 -0.20 (-0.77%)
At close: Oct 20, 2026 · 4:00 PM EDT

Amphastar Pharmaceuticals (AMPH) Receivables (2013 - 2026)

Updated

Amphastar Pharmaceuticals (AMPH) posted Receivables of $145.76 million for Q2 2026, up 9.2% from $133.48 million a year earlier but down 1.9% from the prior quarter.

Analysis

Amphastar Pharmaceuticals (AMPH) Receivables (2013 - 2026) Analysis & Trends

At the end of FY2025, Amphastar Pharmaceuticals' Receivables came in at $143.56 million, up 5.2% from FY2024.

  • Annual Receivables has increased for six consecutive years, with a five-year compound annual growth rate of 16.8% (FY2020 to FY2025).
  • In prior years, Amphastar Pharmaceuticals' Receivables was $136.49 million in FY2024 (+18.7%), $114.94 million in FY2023 (+28.9%), $89.2 million in FY2022 (+13.2%) and $78.8 million in FY2021 (+19.4%).
  • Quarterly Receivables has run from a low of $73.17 million in Q1 2022 to a high of $148.55 million in Q1 2026 over five years.
  • On a year-over-year basis, Receivables has increased in each of the last 15 quarters, with growth averaging 8.1% over the last eight quarters.
  • The strongest year-over-year quarter for Receivables in the past five years was Q3 2023, with growth of 53.9%; the weakest was Q1 2022, with a decline of 6.1%.
  • According to Business Quant data, Receivables for the three prior quarters was $148.55 million (Q1 2026), $143.56 million (Q4 2025) and $147.31 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 23.48 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn 19.05 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn 13.82 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn 12.56 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 9.64 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn 15.68 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn 10.23 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn 5.06 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn 12.49 Bn
10 Amphastar Pharmaceuticals 1.13 Bn -10.28 Mn 93.47 Mn 145.76 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 145.76 Mn
Mar 31, 2026 148.55 Mn
Dec 31, 2025 143.56 Mn
Sep 30, 2025 147.31 Mn
Jun 30, 2025 133.48 Mn
Mar 31, 2025 144.84 Mn
Dec 31, 2024 136.49 Mn
Sep 30, 2024 140.04 Mn
Jun 30, 2024 131.71 Mn
Mar 31, 2024 138.41 Mn
Dec 31, 2023 114.94 Mn
Sep 30, 2023 118.99 Mn
Jun 30, 2023 104.72 Mn
Mar 31, 2023 100.84 Mn
Dec 31, 2022 89.20 Mn
Sep 30, 2022 77.30 Mn
Jun 30, 2022 80.81 Mn
Mar 31, 2022 73.17 Mn
Dec 31, 2021 78.80 Mn
Sep 30, 2021 78.09 Mn
API Access

Amphastar Pharmaceuticals Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables&ticker=AMPH&period=max&api_key=YOUR_API_KEY